AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...
Researchers have developed a simple model system that can be used to break down fibrils -- the cause of numerous disorders including Alzheimer's and Parkinson's disease -- into their constituent ...
GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...
When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
1don MSN
The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
Nottinghamshire Live on MSN3h
Nightmares could be a symptom of serious illnesses like Parkinson's or heart problemsNightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback